Table 5: Overall survival.

OverallFirst-line chemoSecond-line chemoThird-line chemoFourth-line chemoPhase 1 drug trialBest supportive care

Number of patients 81 50 28 15 7 8 48
Overall survival in weeks (Range) 38.7
(1–212)
48.6
(3–200)
43.0
(1–151)
15.8
(5–100)
13.6
(9–27)
14.9
(1–46)
3.4
(1–62)